Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (141-150 of 266) with videos related to

Pageof 27
Sort By:
Urologic Oncology|September 2, 2014
Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trialNallasivam Palanisamy, Alexi Tsodikov, Wei Yan, et al.
The Journal of Urology|February 17, 2012
Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort studyDavid Margel, Stanley A Yap, Nathan Lawrentschuk, et al.
The Canadian Journal of Urology|February 17, 2001
Canadian family physicians and prostate cancer: a national surveyRoss E. Gray, June Carroll, Vivek Goel, et al.
European Urology Oncology|October 30, 2021
Epidemiology and Prevention of Prostate CancerGiorgio Gandaglia, Riccardo Leni, Freddie Bray, et al.
Cancers|July 24, 2021
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate CancerAmeya D Puranik, Clarisse Dromain, Neil Fleshner, et al.
Urology|June 16, 2012
Results of a surgically derived nomogram to predict Gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapyDavid Bowes, Juanita M Crook, Kris Wallace, et al.
The Journal of Urology|June 29, 2016
Stricter Active Surveillance Criteria for Prostate Cancer do Not Result in Significantly Better Outcomes: A Comparison of Contemporary ProtocolsMaria Komisarenko, Narhari Timilshina, Patrick O Richard, et al.
European Urology|April 2, 2013
Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasterideRoberto L Muller, Leah Gerber, Daniel M Moreira, et al.
Urology|September 2, 2024
Statin Concentration in Prostatic Tissue is Subtype- and Dose-dependentJulian Chavarriaga, Linda Z Penn, Najia Khurram, et al.
Oncology Letters|July 12, 2017
Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumorsEkaterina Olkhov-Mitsel, Farshid Siadat, Ken Kron, et al.
Pageof 27

Showing results (141-150 of 266) with videos related to

Sort By:
Pageof 27
Urologic Oncology|September 2, 2014
Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trialNallasivam Palanisamy, Alexi Tsodikov, Wei Yan, et al.
The Journal of Urology|February 17, 2012
Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort studyDavid Margel, Stanley A Yap, Nathan Lawrentschuk, et al.
The Canadian Journal of Urology|February 17, 2001
Canadian family physicians and prostate cancer: a national surveyRoss E. Gray, June Carroll, Vivek Goel, et al.
European Urology Oncology|October 30, 2021
Epidemiology and Prevention of Prostate CancerGiorgio Gandaglia, Riccardo Leni, Freddie Bray, et al.
Cancers|July 24, 2021
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate CancerAmeya D Puranik, Clarisse Dromain, Neil Fleshner, et al.
Urology|June 16, 2012
Results of a surgically derived nomogram to predict Gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapyDavid Bowes, Juanita M Crook, Kris Wallace, et al.
The Journal of Urology|June 29, 2016
Stricter Active Surveillance Criteria for Prostate Cancer do Not Result in Significantly Better Outcomes: A Comparison of Contemporary ProtocolsMaria Komisarenko, Narhari Timilshina, Patrick O Richard, et al.
European Urology|April 2, 2013
Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasterideRoberto L Muller, Leah Gerber, Daniel M Moreira, et al.
Urology|September 2, 2024
Statin Concentration in Prostatic Tissue is Subtype- and Dose-dependentJulian Chavarriaga, Linda Z Penn, Najia Khurram, et al.
Oncology Letters|July 12, 2017
Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumorsEkaterina Olkhov-Mitsel, Farshid Siadat, Ken Kron, et al.
Pageof 27